Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation
Clinical trial NCT03708133 · COMPLETED
Trial details
- NCT number
- NCT03708133
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2019-04-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.